Allakos Inc.

Historical 13F Holders

Symbol: ALLK
CUSIP: 01671P100
All holders as of: Q1 2025
Type: Equity
Class: COM

Reported Value, Excluding Options

Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 01671P100 since 12/18/2024, largest first.

Filer	% of Class	Shares	Form	Filed
Tang Capital Management LLC 13D/A	100.0%	10,000	13D/A	5/19/2025 Event 5/15/2025
Tang Capital Management, LLC	100.0%	10,000
Kevin Tang	100.0%	10,000
Tang Capital Partners, LP	100.0%	10,000
Tang Capital Partners International, LP	0%	0
Tang Capital Partners III, Inc	0%	0
Tang Capital Partners IV, Inc	0%	0
Concentra Biosciences, LLC	100.0%	10,000
Concentra Merger Sub III, Inc	0%	0
Under 5%, checked the "5 percent or less" box, or amended by a later filing (5)
FMR LLC 13G/A	0.3%	271,314	13G/A	5/12/2025 Event 3/31/2025
FMR LLC	0.3%	271,314
Abigail P. Johnson	0.3%	271,314
Biotechnology Value Fund L P 13G/A	0%	0	13G/A	5/19/2025 Event 5/15/2025
Biotechnology Value Fund L P	0%	0
BVF I GP LLC	0%	0
Biotechnology Value Fund II LP	0%	0
BVF II GP LLC	0%	0
Biotechnology Value Trading Fund OS LP	0%	0
BVF Partners OS Ltd.	0%	0
BVF GP Holdings LLC	0%	0
BVF Partners L P/IL	0%	0
BVF Inc/IL	0%	0
Lampert Mark N	0%	0
Beryl Capital Management LLC 13G/A	0%	0	13G/A	8/14/2025 Event 6/30/2025
Beryl Capital Management LLC	0%	0
Beryl Capital Management LP	0%	0
Beryl Capital Partners II LP	0%	0
David A. Witkin	0%	0
Deep Track Capital, LP 13G/A	0%	0	13G/A	8/14/2025 Event 6/30/2025
Deep Track Capital, LP	0%	0
Deep Track Biotechnology Master Fund, Ltd.	0%	0
David Kroin	0%	0
New Enterprise Associates 16, L.P. 13D/A	0%	0	13D/A	5/16/2025 Event 5/15/2025
New Enterprise Associates 16, L.P.	0%	0
NEA Partners 16, L.P.	0%	0
Nea 16 GP, LLC	0%	0
NEA 18 Venture Growth Equity, L.P.	0%	0
NEA Partners 18 VGE, L.P.	0%	0
Nea 18 Vge GP, LLC	0%	0
Ali Behbahani	0%	0
Carmen Chang	0%	0
Anthony A. Florence, Jr.	0%	0
Mohamad H. Makhzoumi	0%	0
Scott D. Sandell	0%	0
Peter W. Sonsini	0%	0
Paul Walker	0%	0

13F Holders by Quarter

Period	Filings	Shares, Excl. Options	Value, Excl. Options	Options Value
2025 Q1	68	61.9 M	$15.4 M	$20.8 k
2024 Q4	81	74.3 M	$90.0 M	$25.3 k
2024 Q3	83	70.3 M	$45.9 M	$31.4 k
2024 Q2	109	80.4 M	$80.3 M	$45.2 k
2024 Q1	109	85.2 M	$107 M	$92.6 k
2023 Q4	119	78.8 M	$215 M	$1.21 M
2023 Q3	123	72.4 M	$164 M	$827 k
2023 Q2	136	70.1 M	$306 M	$123 k
2023 Q1	134	68.4 M	$304 M	$108 k
2022 Q4	135	72.9 M	$614 M	$2.39 M
2022 Q3	110	65.3 M	$396 M	$2.99 M
2022 Q2	111	35.1 M	$110 M	$305 k
2022 Q1	147	37.5 M	$221 M	$2.45 M
2021 Q4	174	33.7 M	$337 M	$33.0 M
2021 Q3	188	44.7 M	$4.73 B	$90.6 M
2021 Q2	184	44.8 M	$3.83 B	$28.0 M
2021 Q1	183	44.2 M	$5.06 B	$38.8 M
2020 Q4	179	43.0 M	$6.01 B	$65.9 M
2020 Q3	146	34.6 M	$2.82 B	$20.2 M
2020 Q2	146	35.4 M	$2.54 B	$26.5 M
2020 Q1	131	34.1 M	$1.52 B	$9.32 M
2019 Q4	145	32.5 M	$3.10 B	$84.4 M
2019 Q3	119	33.5 M	$2.63 B	$30.3 M
2019 Q2	77	25.3 M	$1.09 B	$975 k
2019 Q1	75	22.9 M	$928 M	$0
2018 Q4	67	17.5 M	$905 M	$0
2018 Q3	73	16.1 M	$713 M	$0